Children’s Oncology Group (COG) Trials for Retinoblastoma

Dan S Gombos; Anna T. Meadows; Murali Chintagumpala; Ira J. Dunkel; Debra Friedman; Julie Ann Stoner; Rima Jubran; Judith Grob Villablanca

doi:10.1007/978-3-662-43451-2_21

Children’s Oncology Group (COG) Trials for Retinoblastoma

Dan S Gombos, Anna T. Meadows, Murali Chintagumpala, Ira J. Dunkel, Debra Friedman, Julie Ann Stoner, Rima Jubran, Judith Grob Villablanca

Head & Neck Surgery

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

For the past 30 years, retinoblastoma, a tumor that occurs in only 3 % of children with cancer, has been the subject of extensive molecular biologic research. However, apart from a short period in the 1970s, retinoblastoma has not been studied by any of the pediatric cooperative groups. The past decade has witnessed significant multidisciplinary prospective clinical and biologic studies of this rare pediatric neoplasm. The Children’s Oncology Group (COG) has successfully opened four clinical trials with a fifth recently approved. This chapter will review these ongoing prospective multicenter trials.

Original language	English (US)
Title of host publication	Clinical Ophthalmic Oncology
Subtitle of host publication	Retinoblastoma, Second Edition
Publisher	Springer Berlin Heidelberg
Pages	215-223
Number of pages	9
ISBN (Electronic)	9783662434512
ISBN (Print)	9783662434505
DOIs	https://doi.org/10.1007/978-3-662-43451-2_21
State	Published - Jan 1 2015

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-3-662-43451-2_21

Cite this

@inbook{703e570f32404765afeff0b78e9e3e33,

title = "Children{\textquoteright}s Oncology Group (COG) Trials for Retinoblastoma",

abstract = "For the past 30 years, retinoblastoma, a tumor that occurs in only 3 % of children with cancer, has been the subject of extensive molecular biologic research. However, apart from a short period in the 1970s, retinoblastoma has not been studied by any of the pediatric cooperative groups. The past decade has witnessed significant multidisciplinary prospective clinical and biologic studies of this rare pediatric neoplasm. The Children{\textquoteright}s Oncology Group (COG) has successfully opened four clinical trials with a fifth recently approved. This chapter will review these ongoing prospective multicenter trials.",

author = "Gombos, {Dan S} and Meadows, {Anna T.} and Murali Chintagumpala and Dunkel, {Ira J.} and Debra Friedman and Stoner, {Julie Ann} and Rima Jubran and Villablanca, {Judith Grob}",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-662-43451-2_21",

language = "English (US)",

isbn = "9783662434505",

pages = "215--223",

booktitle = "Clinical Ophthalmic Oncology",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Children’s Oncology Group (COG) Trials for Retinoblastoma

AU - Gombos, Dan S

AU - Meadows, Anna T.

AU - Chintagumpala, Murali

AU - Dunkel, Ira J.

AU - Friedman, Debra

AU - Stoner, Julie Ann

AU - Jubran, Rima

AU - Villablanca, Judith Grob

PY - 2015/1/1

Y1 - 2015/1/1

N2 - For the past 30 years, retinoblastoma, a tumor that occurs in only 3 % of children with cancer, has been the subject of extensive molecular biologic research. However, apart from a short period in the 1970s, retinoblastoma has not been studied by any of the pediatric cooperative groups. The past decade has witnessed significant multidisciplinary prospective clinical and biologic studies of this rare pediatric neoplasm. The Children’s Oncology Group (COG) has successfully opened four clinical trials with a fifth recently approved. This chapter will review these ongoing prospective multicenter trials.

AB - For the past 30 years, retinoblastoma, a tumor that occurs in only 3 % of children with cancer, has been the subject of extensive molecular biologic research. However, apart from a short period in the 1970s, retinoblastoma has not been studied by any of the pediatric cooperative groups. The past decade has witnessed significant multidisciplinary prospective clinical and biologic studies of this rare pediatric neoplasm. The Children’s Oncology Group (COG) has successfully opened four clinical trials with a fifth recently approved. This chapter will review these ongoing prospective multicenter trials.

UR - http://www.scopus.com/inward/record.url?scp=84956763017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956763017&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-43451-2_21

DO - 10.1007/978-3-662-43451-2_21

M3 - Chapter

AN - SCOPUS:84956763017

SN - 9783662434505

SP - 215

EP - 223

BT - Clinical Ophthalmic Oncology

PB - Springer Berlin Heidelberg

ER -

Children’s Oncology Group (COG) Trials for Retinoblastoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this